Evidence map›Paper›PMID 34255666›Full record

ArticleJournal of medical Internet research2021

Approaches for Implementing App-Based Digital Treatments for Drug Use Disorders Into Primary Care: A Qualitative, User-Centered Design Study of Patient Perspectives.

Joseph E Glass, Theresa E Matson, Catherine Lim, Andrea L Hartzler, Kilian Kimbel, Amy K Lee, Tara Beatty, Rebecca Parrish, Ryan M Caldeiro, Angela Garza McWethy and 2 more

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Adoption of Digital Therapeutics in Europe.Therapeutics and clinical risk management · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Joseph E GlassKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.ORCID 0000-0002-2923-3698
Theresa E MatsonKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.ORCID 0000-0002-4551-7981
Catherine LimKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.ORCID 0000-0001-7708-4802
Andrea L HartzlerDepartment of Biomedical Informatics and Medical Education, School of Medicine, University of Washington, Seattle, WA, United States.ORCID 0000-0003-4932-7314
Kilian KimbelKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.ORCID 0000-0002-7587-1084
Amy K LeeKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.ORCID 0000-0002-5713-5374
Tara BeattyKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.ORCID 0000-0002-1478-5238
Rebecca ParrishKaiser Permanente Washington Mental Health & Wellness Services, Renton, WA, United States.ORCID 0000-0003-3380-9079
Ryan M CaldeiroKaiser Permanente Washington Mental Health & Wellness Services, Renton, WA, United States.ORCID 0000-0003-3224-8425
Angela Garza McWethyKaiser Permanente Washington Mental Health & Wellness Services, Renton, WA, United States.ORCID 0000-0003-2506-1224
Geoffrey M CurranUniversity of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, AR, United States.ORCID 0000-0003-3464-8422
Katharine A BradleyKaiser Permanente Washington Health Research Institute, Seattle, WA, United States.ORCID 0000-0003-1933-4425

Funding

Expanding Translational Research in ArkansasUL1TR003107 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI JAMES, LAURA P · 2019 to 2023
$21.6M
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: Observational Analysis of Adaptions to the InterventionR01DA047954 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI GLASS, JOSEPH EDWIN · 2019 to 2023
$3.9M
A game-based intervention for Opioid Use DisorderR44DA042652 · NIDA · PEAR THERAPEUTICS, INC. · PI LUDERER, HILARY F · 2017 to 2020
$1.2M
Decreasing the Engagement Gap for Addiction Treatment in Primary CareK01AA023859 · NIAAA · KAISER FOUNDATION RESEARCH INSTITUTE · PI GLASS, JOSEPH EDWIN · 2017 to 2021
$931k
Training Clinicians in Implementation Research to Improve Alcohol-related CareK24AA022128 · NIAAA · KAISER FOUNDATION RESEARCH INSTITUTE · PI BRADLEY, KATHARINE ANTHONY · 2016 to 2020
$876k
NCATS NIH HHS UL1 TR003107NIAAA NIH HHS K01 AA023859NIAAA NIH HHS K24 AA022128NIDA NIH HHS R01 DA047954NIDA NIH HHS R44 DA042652
6 · The paper itself

Abstract

backgroundDigital interventions, such as websites and smartphone apps, can be effective in treating drug use disorders (DUDs). However, their implementation in primary care is hindered, in part, by a lack of knowledge on how patients might like these treatments delivered to them.

objectiveThis study aims to increase the understanding of how patients with DUDs prefer to receive app-based treatments to inform the implementation of these treatments in primary care.

methodsThe methods of user-centered design were combined with qualitative research methods to inform the design of workflows for offering app-based treatments in primary care. Adult patients (n=14) with past-year cannabis, stimulant, or opioid use disorder from 5 primary care clinics of Kaiser Permanente Washington in the Seattle area participated in this study. Semistructured interviews were recorded, transcribed, and analyzed using qualitative template analysis. The coding scheme included deductive codes based on interview topics, which primarily focused on workflow design. Inductive codes emerged from the data.

resultsParticipants wanted to learn about apps during visits where drug use was discussed and felt that app-related conversations should be incorporated into the existing care whenever possible, as opposed to creating new health care visits to facilitate the use of the app. Nearly all participants preferred receiving clinician support for using apps over using them without support. They desired a trusting, supportive relationship with a clinician who could guide them as they used the app. Participants wanted follow-up support via phone calls or secure messaging because these modes of communication were perceived as a convenient and low burden (eg, no copays or appointment travel).

conclusionsA user-centered implementation of treatment apps for DUDs in primary care will require health systems to design workflows that account for patients' needs for structure, support in and outside of visits, and desire for convenience.

Indexed as

Mobile ApplicationsSubstance-Related DisordersAdultHumansPrimary Health CareQualitative ResearchUser-Centered Designcannabisdrug use disordersmHealthmobile phoneopioidsprimary carequalitativestimulantsuser-centered design

Identifiers

PMID34255666
PMCPMC8293157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.